Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia

BACKGROUND: The economics of allogeneic hematopoietic cell transplantation (alloHCT) for older patients with acute myeloid leukemia (AML) affects clinical practice and public policy. To assess reimbursement, utilization, and overall survival (OS) up to 1 year post-alloHCT for Medicare beneficiaries...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JNCI Cancer Spectr
Main Authors: Mau, Lih-Wen, Meyer, Christa, Burns, Linda J, Saber, Wael, Steinert, Patricia, Vanness, David J, Preussler, Jaime M, Silver, Alicia, Leppke, Susan, Murphy, Elizabeth A, Denzen, Ellen
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6845850/
https://ncbi.nlm.nih.gov/pubmed/31750417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkz048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados